Companies/IN/IBN

ICICI BANK LIMITED

Last · NSE₹1338.60-21.60 (-1.59%)close · yahoo · 15h ago
Vol 8.25M ≈ 11.05B
Market cap₹9.61T7.18B sh
P/E · TTM17.3fwd 14.3 · eps 77.36
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
₹1187.60₹1480.00
Volume8.3Msession

Issuer

Legal nameICICI BANK LIMITED
HQIndia (IN)
ListingIN IBN
ISININE090A01021
SectorFinancials
IndustryBanks
CurrencyINR
Entity registrynse:ICICIBANK
CIK0001103838
LinkedIn
Employees182,665
AddressICICI Bank Ltd. ICICI Bank Towers 400051, Mumbai +91 22 4008 6173
Headline financial metrics
Revenue₹483.7B
Operating income₹168.9B
Net income₹117.9B
Operating margin34.9%
Net margin24.4%
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Strong growth, stable underlying margins, ample provisioning buffers, and contained credit risk outweigh the unresolved agri, FCNR, and competitive-pricing risks.

Latest call · Q1 2026

Buy: ICICI Bank delivered a strong Q1-FY27 with profit before tax excluding treasury up 20.9% year over year, PAT up 15.9%, loans up 19.6%, and deposits up 14.0%.

The bull case is unusually strong growth without material margin or credit deterioration: reported NIM was 4.36% and 4.28% excluding tax-refund benefit, while net NPA rose only modestly to 0.35%. The key tension is that some corporate growth reflects bond-market substitution and working-capital demand, while normalized credit cost is closer to 50 bps and several future earnings levers remain unquantified.

Themes
  • Loan Growth
  • Nim Resilience
  • Credit Quality
  • Business Banking
  • Fc Nr Deposits
  • Ecl Transition
+2

Near term

Monitor whether loan growth moderates from the 19.6% year-on-year headline as base effects and bond-market substitution fade.

FCNR(B) mobilization over the next 8–10 weeks could expand overseas loans and earnings, but management expects possible NIM pressure and provided no target.

Agri/KCC remediation and regulator validation could determine the timing of any provision write-back; management gave no timeline.

Reported credit cost of 32 bps benefited from a chunky NCLT-related recovery; management indicated roughly 50 bps is the normalized level.

Fee income growth of 23.5% benefited from a weak prior-year base and should be tested against sequential and underlying growth.

Longer term

The franchise is gaining volume across business banking, corporate, mortgages, personal loans, and rural lending, supported by 16.19% CET1 and contingency provisions of ₹131.0 billion.

Underlying margin resilience is a strength: excluding tax-refund benefit, NIM was 4.28% versus 4.27% in the prior quarter and year-ago quarter, despite faster corporate growth.

ECL transition appears absorbable through existing buffers, but recurring Stage 2 provisioning will raise reported credit costs across the sector.

Competitive intensity, particularly from PSU banks, remains unresolved; management avoided quantifying asset-pricing improvement and said it is selecting only risk-adjusted opportunities.

ICICI Life and AMC are improving, but the general-insurance subsidiary remains a drag, with a 107.2% combined ratio and Q1 PAT down to ₹4.03 billion from ₹7.47 billion.

Red flags

Corporate and business-banking net NPA additions increased to ₹5.86 billion from ₹3.66 billion a year ago, even as management described the portfolio as stable.

Management would not quantify the FCNR(B) opportunity or its eventual margin/profitability impact; the program may materially expand the international balance sheet.

The anticipated agricultural provision reversal remains dependent on field-work validation and sign-off, with no timing disclosed.

Management did not provide a sustainable loan-growth or personal-loan run-rate outlook, and acknowledged that average growth will be below the 19.6% period-end figure.

Management cited stable pricing only assuming no policy-rate movements, leaving the margin outlook exposed to liquidity, rates, and competition.

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

Upcoming earnings

1 event
12:00 PM UTC+2
Period
Sep 2026
Est. EPS
$18.15
Est. revenue
337.7B

Earnings transcripts

1 recent

Press & signals

1 recent
  • Satelight

    UPI: Anatomy of a Payment Transaction

Documents

FormReporting forFiledFlags
—2027-03-31≈0
—2026-12-31≈0